JP2015506689A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015506689A5 JP2015506689A5 JP2014554824A JP2014554824A JP2015506689A5 JP 2015506689 A5 JP2015506689 A5 JP 2015506689A5 JP 2014554824 A JP2014554824 A JP 2014554824A JP 2014554824 A JP2014554824 A JP 2014554824A JP 2015506689 A5 JP2015506689 A5 JP 2015506689A5
- Authority
- JP
- Japan
- Prior art keywords
- gene
- virus
- expression vector
- nucleotide sequence
- viral expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261590056P | 2012-01-24 | 2012-01-24 | |
| US201261590070P | 2012-01-24 | 2012-01-24 | |
| US61/590,056 | 2012-01-24 | ||
| US61/590,070 | 2012-01-24 | ||
| US201261683810P | 2012-08-16 | 2012-08-16 | |
| US61/683,810 | 2012-08-16 | ||
| PCT/US2013/022962 WO2013112720A1 (en) | 2012-01-24 | 2013-01-24 | Parainfluenza virus 5 based vaccines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017198111A Division JP2018050624A (ja) | 2012-01-24 | 2017-10-12 | パラインフルエンザウイルス５型ベースのワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015506689A JP2015506689A (ja) | 2015-03-05 |
| JP2015506689A5 true JP2015506689A5 (enExample) | 2016-03-10 |
| JP6228136B2 JP6228136B2 (ja) | 2017-11-08 |
Family
ID=48873896
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014554824A Active JP6228136B2 (ja) | 2012-01-24 | 2013-01-24 | パラインフルエンザウイルス５型ベースのワクチン |
| JP2017198111A Pending JP2018050624A (ja) | 2012-01-24 | 2017-10-12 | パラインフルエンザウイルス５型ベースのワクチン |
| JP2019168928A Active JP6900437B2 (ja) | 2012-01-24 | 2019-09-18 | パラインフルエンザウイルス５型ベースのワクチン |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017198111A Pending JP2018050624A (ja) | 2012-01-24 | 2017-10-12 | パラインフルエンザウイルス５型ベースのワクチン |
| JP2019168928A Active JP6900437B2 (ja) | 2012-01-24 | 2019-09-18 | パラインフルエンザウイルス５型ベースのワクチン |
Country Status (13)
| Country | Link |
|---|---|
| US (6) | US9505807B2 (enExample) |
| EP (2) | EP2806891B1 (enExample) |
| JP (3) | JP6228136B2 (enExample) |
| CN (2) | CN104093422B (enExample) |
| AU (1) | AU2013212097B2 (enExample) |
| BR (1) | BR112014018179B1 (enExample) |
| CA (2) | CA2860388C (enExample) |
| ES (1) | ES2728248T3 (enExample) |
| MX (1) | MX359638B (enExample) |
| MY (1) | MY173638A (enExample) |
| PH (1) | PH12014501255B1 (enExample) |
| PT (1) | PT2806891T (enExample) |
| WO (2) | WO2013112690A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3123276A1 (en) | 2011-02-25 | 2012-08-30 | University Of Georgia Research Foundation, Inc. | Recombinant mumps virus vaccine |
| AU2013212097B2 (en) | 2012-01-24 | 2017-01-12 | University Of Georgia Research Foundation, Inc. | Parainfluenza virus 5 based vaccines |
| KR101577397B1 (ko) * | 2014-01-15 | 2015-12-28 | 경북대학교 산학협력단 | 신규한 돼지 파라인플루엔자 바이러스 5(pPIV5), 이를 포함하는 백신 조성물 및 이를 이용한 돼지 파라인플루엔자 바이러스 검정 키트 |
| EP3288595B1 (en) * | 2015-04-28 | 2020-12-30 | The University Of Georgia Research Foundation, Inc. | Piv5-based amplifying virus-like particles |
| US20180339038A1 (en) * | 2015-06-12 | 2018-11-29 | Mie University | Human parainfluenza virus type 2 vector and vaccine |
| IL270876B2 (en) * | 2017-05-25 | 2024-06-01 | Univ Central Florida Res Found Inc | Novel oncolytic viruses for sensitizing tumor cells to killing by natural killer cells |
| RU2681473C1 (ru) * | 2018-01-16 | 2019-03-06 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" | Тест-система для обнаружения генома вируса парагриппа 3 типа у крупного рогатого скота с помощью мультиплексной полимеразной цепной реакции с флуоресцентной детекцией в режиме реального времени |
| GB201816873D0 (en) * | 2018-10-17 | 2018-11-28 | Imperial Innovations Ltd | Fusion protein |
| WO2020092207A1 (en) * | 2018-10-28 | 2020-05-07 | University Of Georgia Research Foundation | Broadly reactive immunogens of influenza virus, compositions, and methods of use thereof |
| CL2018003869A1 (es) * | 2018-12-28 | 2021-01-15 | Univ Pontificia Catolica Chile | Anticuerpos monoclonales específicos para la proteína quimérica l del virus de la parainfluenza humana (piv), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por piv |
| CA3196157A1 (en) * | 2020-09-21 | 2022-03-24 | University Of Georgia Research Foundation, Inc. | Piv5-based covid-19 vaccine |
| US20240102912A1 (en) * | 2020-11-09 | 2024-03-28 | Thrive Bioscience, Inc. | Plaque counting assay method |
| CN113005149A (zh) * | 2021-03-26 | 2021-06-22 | 中国农业大学 | 一种表达冠状病毒受体结合域串联二聚体的重组副流感病毒5型载体 |
| AU2022332107A1 (en) * | 2021-08-26 | 2024-03-14 | University Of Georgia Research Foundation, Inc. | J paramyxovirus vaccines |
| GB202209861D0 (en) * | 2022-07-05 | 2022-08-17 | Univ Court Univ St Andrews | Viral vectors |
| AU2023372210A1 (en) * | 2022-11-04 | 2025-05-29 | Blue Lake Biotechnology, Inc. | Recombinant rsv vaccine: methods of making and using the same |
| JP2026504603A (ja) * | 2023-02-06 | 2026-02-05 | サイアンバック エルエルシー | 修飾ｐｉｖ５ワクチンベクター：作製方法及び使用方法 |
| CN116270766A (zh) * | 2023-02-23 | 2023-06-23 | 天津理工大学 | 一种副流感病毒5型作为溶瘤病毒在抗肿瘤中的应用 |
| CN117625560B (zh) * | 2023-11-03 | 2025-09-16 | 中国农业大学 | 一种重组病毒rPIV5-H3及其制备方法、应用和疫苗 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6638762B1 (en) | 1994-11-28 | 2003-10-28 | Genetic Therapy, Inc. | Tissue-vectors specific replication and gene expression |
| CA2160038A1 (en) * | 1995-07-14 | 1997-01-15 | Biosignal Inc. | Methods of screening compounds for their pharmacological relevance based on downregulation of recombinant receptors |
| JP2000509280A (ja) | 1996-05-01 | 2000-07-25 | アメリカ合衆国 | 組換えｄｎａ由来ヌクレオキャプシドタンパク質を用いるウイルストランスフェクタントの作製 |
| US6410023B1 (en) * | 1997-05-23 | 2002-06-25 | United States Of America | Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
| US5962274A (en) | 1998-03-13 | 1999-10-05 | Wake Forest University | Viral vector directed to predetermined target cells |
| CN102766605A (zh) * | 1999-12-10 | 2012-11-07 | 由卫生与公众服务部代表的美利坚合众国政府 | 重组副流感病毒(piv)作为载体提供保护对抗piv及其他人类病原体引起的感染和疾病的用途 |
| US6764685B1 (en) | 2000-03-21 | 2004-07-20 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines |
| JP2002153278A (ja) | 2000-11-22 | 2002-05-28 | Hisamitsu Pharmaceut Co Inc | ウイルスベクターの製造に用いられる細胞、その製法およびその細胞を用いたウイルスベクターの製造方法 |
| AU2002327755A1 (en) | 2001-09-28 | 2003-04-14 | Rush-Presbyterian-St. Luke's Medical Center | Paramyxoviruses as gene transfer vectors to lung cells |
| WO2005005645A1 (en) | 2003-06-13 | 2005-01-20 | Apath, Llc | Negative strand rna virus replicon |
| DK2540312T3 (en) | 2007-07-19 | 2015-07-20 | Novavax Inc | Chimeric avian influenza VLPs |
| US20090208495A1 (en) | 2008-02-14 | 2009-08-20 | Bayer Schering Pharma Ag | Anti-tumor effective paramyxovirus |
| FR2938840B1 (fr) | 2008-11-21 | 2010-12-17 | Centre Nat Rech Scient | Proteines mutantes de la proteine f de piv-5 et de piv-2 |
| US10227569B2 (en) | 2011-04-12 | 2019-03-12 | Emory University | Respiratory syncytial virus expression vectors |
| AU2013212097B2 (en) | 2012-01-24 | 2017-01-12 | University Of Georgia Research Foundation, Inc. | Parainfluenza virus 5 based vaccines |
-
2013
- 2013-01-24 AU AU2013212097A patent/AU2013212097B2/en active Active
- 2013-01-24 PT PT13741216T patent/PT2806891T/pt unknown
- 2013-01-24 MX MX2014008557A patent/MX359638B/es active IP Right Grant
- 2013-01-24 US US14/374,061 patent/US9505807B2/en active Active
- 2013-01-24 EP EP13741216.9A patent/EP2806891B1/en active Active
- 2013-01-24 WO PCT/US2013/022898 patent/WO2013112690A1/en not_active Ceased
- 2013-01-24 JP JP2014554824A patent/JP6228136B2/ja active Active
- 2013-01-24 WO PCT/US2013/022962 patent/WO2013112720A1/en not_active Ceased
- 2013-01-24 CN CN201380006495.2A patent/CN104093422B/zh active Active
- 2013-01-24 CA CA2860388A patent/CA2860388C/en active Active
- 2013-01-24 CA CA3128591A patent/CA3128591A1/en active Pending
- 2013-01-24 EP EP19165071.2A patent/EP3536341A1/en active Pending
- 2013-01-24 ES ES13741216T patent/ES2728248T3/es active Active
- 2013-01-24 MY MYPI2014702016A patent/MY173638A/en unknown
- 2013-01-24 US US14/374,070 patent/US9732358B2/en active Active
- 2013-01-24 BR BR112014018179-9A patent/BR112014018179B1/pt active IP Right Grant
- 2013-01-24 CN CN201810061733.4A patent/CN108130345A/zh active Pending
-
2014
- 2014-06-04 PH PH12014501255A patent/PH12014501255B1/en unknown
-
2016
- 2016-10-18 US US15/296,346 patent/US10752916B2/en active Active
-
2017
- 2017-06-30 US US15/638,946 patent/US10329585B2/en active Active
- 2017-10-12 JP JP2017198111A patent/JP2018050624A/ja active Pending
-
2019
- 2019-05-24 US US16/421,837 patent/US20190284578A1/en not_active Abandoned
- 2019-09-18 JP JP2019168928A patent/JP6900437B2/ja active Active
-
2020
- 2020-08-10 US US16/989,038 patent/US11542527B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015506689A5 (enExample) | ||
| Imai et al. | The role of receptor binding specificity in interspecies transmission of influenza viruses | |
| Bouvier et al. | The biology of influenza viruses | |
| Cheung et al. | Biology of influenza a virus | |
| JP2014504500A5 (enExample) | ||
| US8828406B2 (en) | Influenza viruses and uses thereof | |
| Neumann et al. | Reverse genetics of influenza virus | |
| Gambotto et al. | Human infection with highly pathogenic H5N1 influenza virus | |
| CA2631812C (en) | Chimeric viruses presenting non-native surface proteins and uses thereof | |
| US9217157B2 (en) | Recombinant influenza viruses and uses thereof | |
| JP5491173B2 (ja) | イヌ細胞中でマイナス鎖ウイルスｒｎａを発現させるための方法および組成物 | |
| US20190125859A1 (en) | Influenza virus vaccination regimens | |
| RU2013135498A (ru) | Экспрессионные системы | |
| Neumann et al. | Generation of influenza A virus from cloned cDNAs—historical perspective and outlook for the new millenium | |
| WO2008147496A2 (en) | Neuraminidase-deficient live influenza vaccines | |
| WO2021081120A1 (en) | Recombinant neuraminidase and uses thereof | |
| Ye et al. | Mutation from arginine to lysine at the position 189 of hemagglutinin contributes to the antigenic drift in H3N2 swine influenza viruses | |
| Horimotob | Viruses–Applications in Research and Vaccine Design | |
| Steel | New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges | |
| Hatta et al. | Reverse genetics approach towards understanding pathogenesis of H5N1 Hong Kong influenza A virus infection | |
| Ye et al. | Influenza reverse genetics: dissecting immunity and pathogenesis | |
| An et al. | Generation of highly productive and mammalian nonpathogenic recombinant H9N2 avian influenza viruses by optimization of 3’end promoter and NS genome | |
| CN104704112A (zh) | 传染性流感病毒的生产 | |
| Chang et al. | Avian influenza virus: the threat of a pandemic | |
| Finch et al. | Design of alternative live attenuated influenza virus vaccines |